What are Amneal Pharmaceuticals, Inc.'s profit margins?

Amneal Pharmaceuticals, Inc. (AMRX) runs a 38.7% gross margin and a 14.3% operating margin, with a 4.0% net margin.

Where do Amneal Pharmaceuticals, Inc.'s ratios come from?

Every ratio is computed from Amneal Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Amneal Pharmaceuticals, Inc. AMRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	38.7%+1.8pp	36.9%+0.1pp	36.8%-0.9pp	37.7%+1.0pp	36.7%+0.2pp
Operating margin	14.3%+1.2pp	13.1%+0.9pp	12.2%-1.0pp	13.2%+0.5pp	12.7%+3.8pp
Net margin	4%+1.6pp	2.4%+2.2pp	0.2%+0.1pp	0.1%+0.6pp	-0.5%+3.7pp
Returns
Return on invested capital	20.1%+4.4pp	15.7%+2.3pp	13.4%+3.3pp	10.1%+0.7pp	9.4%-1.2pp
Efficiency
Asset turnover	0.9×0.0×	0.8×0.0×	0.8×0.0×	0.8×0.0×	0.8×0.0×
Liquidity
Current ratio	2.5×+0.3×	2.2×0.0×	2.1×+0.7×	1.4×0.0×	1.4×0.0×
Per Share
Book value per share	-$0.14+36.7%	-$0.22+35.3%	-$0.34+3.1%	-$0.35+14.4%	-$0.41-14.9%
Valuation
Market capitalization	$3.97B+0.1%	$3.96B+26.0%	$3.14B+23.4%	$2.55B-3.0%	$2.63B+7.0%
Price / earnings	32.5×-22.5×	55×-478×	532.9×-222×	755×—	——
Price / sales	1.3×0.0×	1.3×+0.2×	1.1×+0.2×	0.9×0.0×	0.9×0.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Amneal Pharmaceuticals, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Amneal Pharmaceuticals, Inc.'s profit margins?: Amneal Pharmaceuticals, Inc. (AMRX) runs a 38.7% gross margin and a 14.3% operating margin, with a 4.0% net margin.
Where do Amneal Pharmaceuticals, Inc.'s ratios come from?: Every ratio is computed from Amneal Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.